IL130765A0 - Formulation of stabilised cationic transfection agent(s)/ nucleic acid particles - Google Patents

Formulation of stabilised cationic transfection agent(s)/ nucleic acid particles

Info

Publication number
IL130765A0
IL130765A0 IL13076598A IL13076598A IL130765A0 IL 130765 A0 IL130765 A0 IL 130765A0 IL 13076598 A IL13076598 A IL 13076598A IL 13076598 A IL13076598 A IL 13076598A IL 130765 A0 IL130765 A0 IL 130765A0
Authority
IL
Israel
Prior art keywords
nucleic acid
transfection agent
formulation
acid particles
cationic transfection
Prior art date
Application number
IL13076598A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL130765(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL130765A0 publication Critical patent/IL130765A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13076598A 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/ nucleic acid particles IL130765A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
PCT/FR1998/000222 WO1998034648A1 (fr) 1997-02-10 1998-02-06 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (1)

Publication Number Publication Date
IL130765A0 true IL130765A0 (en) 2001-01-28

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13076598A IL130765A0 (en) 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/ nucleic acid particles

Country Status (20)

Country Link
EP (1) EP1007097B1 (cs)
JP (1) JP2001511171A (cs)
KR (1) KR20000070914A (cs)
AT (1) ATE206932T1 (cs)
AU (1) AU737720B2 (cs)
BR (1) BR9807563A (cs)
CA (1) CA2278665A1 (cs)
CZ (1) CZ282199A3 (cs)
DE (1) DE69802102T2 (cs)
DK (1) DK1007097T3 (cs)
ES (1) ES2166146T3 (cs)
FR (1) FR2759298B1 (cs)
GR (1) GR3036919T3 (cs)
HU (1) HUP0001720A3 (cs)
IL (1) IL130765A0 (cs)
NO (1) NO993825D0 (cs)
PT (1) PT1007097E (cs)
SK (1) SK282685B6 (cs)
WO (1) WO1998034648A1 (cs)
ZA (1) ZA981034B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
WO1999052858A2 (en) * 1998-04-08 1999-10-21 Celltech Therapeutics Limited Lipids
AU747597B2 (en) * 1998-07-20 2002-05-16 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
AU2001241958A1 (en) * 2000-03-03 2001-09-17 Valentis, Inc. Improved poloxamer and poloxamine compositions for nucleic acid delivery
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
CA2426582A1 (en) * 2000-10-20 2002-08-08 Valentis, Inc. Gene delivery formulations and methods for treatment of ischemic conditions
EP1232758A1 (fr) * 2001-02-19 2002-08-21 Aventis Pasteur Polynucléotide formulé en vue d'un transfert intracellulaire amélioré
JP2007527431A (ja) 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
ZA200707352B (en) 2005-03-03 2009-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
AU5527696A (en) * 1995-03-31 1996-10-16 Children's Hospital Medical Center Use of surfactants for introducing genetic material into lun g cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
ES2166146T3 (es) 2002-04-01
SK282685B6 (sk) 2002-11-06
HUP0001720A3 (en) 2001-10-29
AU737720B2 (en) 2001-08-30
NO993825L (no) 1999-08-09
BR9807563A (pt) 2000-02-01
EP1007097B1 (fr) 2001-10-17
PT1007097E (pt) 2002-04-29
DE69802102D1 (de) 2001-11-22
DE69802102T2 (de) 2002-03-14
WO1998034648A1 (fr) 1998-08-13
AU6298798A (en) 1998-08-26
ATE206932T1 (de) 2001-11-15
EP1007097A1 (fr) 2000-06-14
CZ282199A3 (cs) 1999-10-13
JP2001511171A (ja) 2001-08-07
FR2759298B1 (fr) 1999-04-09
HUP0001720A1 (hu) 2000-09-28
NO993825D0 (no) 1999-08-09
ZA981034B (en) 1998-08-11
CA2278665A1 (fr) 1998-08-13
GR3036919T3 (en) 2002-01-31
FR2759298A1 (fr) 1998-08-14
KR20000070914A (ko) 2000-11-25
DK1007097T3 (da) 2002-02-11
SK108299A3 (en) 2000-05-16

Similar Documents

Publication Publication Date Title
GR3036919T3 (en) Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
EP0911039A3 (en) Drug-resin complexes stabilized by chelating agents
IL115742A (en) Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
EP1135173A4 (en) MEDICINAL AEROSOL FORMULATION
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
CA2338358A1 (en) Compounds and compositions for delivering active agents
ZA98792B (en) Bar compositions comprising adjuvant powders for delivering benefit agent and process for the manufacture of said bars.
BR9906916A (pt) Composição de revestimento em pó
AU3438900A (en) Use of trehalose for stabilising a liquid vaccine
MX9804848A (es) Emulsiones estables que comprenden un ingrediente liquido hidrofobico.
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
AU2496199A (en) Copolymer compositions for oral delivery
CA2194979A1 (en) Solid drug forms containing clathrates of steroid sex hormones
HUP9900475D0 (en) O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
YU8701A (sh) Nova oralna kompozicija
MXPA04001411A (es) Vehiculo de suministro de fragancia.
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
BR9811985A (pt) Dispositivo de dosagem
WO2000021577A3 (en) Compositions
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
WO2001006963A3 (en) Orthopaedic bone cement mixing container
EP0891778A3 (en) Agents for the prevention and/or treatment of radiation-induced disorders
MX9708160A (es) Composicion y aparato para la limpieza de superficies.
MX9603741A (es) Composicion de liberacion mantenida.